GlobeNewswire

Car Sharing Goes Up a Gear in London With Expansion of Zipcar Flex

Dela

As private car ownership continues to drop in London, car sharing is taking off

LONDON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zipcar, the world's leading car sharing network, announced  that Zipcar Flex, the Company's 'floating' car sharing service is now available to nearly 3.5m Londoners*.

Zipcar Flex allows members to spontaneously jump into a car and drive one-way across London, with the ability to drop the car off in one of thousands of spaces within the 'Zipzone', which now covers an area of over 235 km2 across North and South London. 

Members who utilise Zipcar Flex pay just 29p per minute and only for the exact time their trip lasts.  Thanks to extras like the Congestion Charge, petrol and insurance being included in the rates, it's now one of the cheapest and most convenient ways to get around London.

London borough councils seem to agree, with Zipcar Flex now available to residents in Wandsworth, Islington, Hackney, Lewisham, Lambeth, Waltham Forest, Southwark and Merton. There are more boroughs in the pipeline as the service gains momentum and is planned to become more widely available, with the aim to get more Londoners to ditch their privately owned cars in favour of shared vehicles.

Zipcar Flex in numbers:

  • 235 km2 - the size of the Flex operating area ('Zipzone') in London i.e. the size of Berlin
  • 3.4m - the number of Londoners the scheme is currently available to
  • 50% - Percentage difference between the cost of a typical Flex trip versus a trip with leading E-hailing companies
  • 700 - the number of brand new VW Polos in the Flex fleet
  • 8 - the number of boroughs in the current 'Zipzone'

Jonathan Hampson, General Manager for Zipcar UK, said: "Car clubs traditionally operate from dedicated fixed bays, but what Zipcar Flex enables is for more Londoners to make smarter transport decisions and experience how much more convenient and cost-effective car sharing is compared to ownership. Zipcar Flex can unlock the potential of car sharing to significantly improve key issues like air quality and congestion for London."

What's more, compared to black cabs and ride-hailing companies, Zipcar Flex can be considered more efficient because journeys avoid so-called 'empty miles.' Cars are only driven when used by members and go point to point, unlike taxis that need to drive to find and pick up passengers before a trip starts. Fewer miles driven results in lower emissions per trip, making the service much more efficient and environmentally friendly.

How Zipcar Flex compares on price for a 20 minute trip in London**:
Transport Cost
Ride-hailing company £12.50
Zipcar Flex £5.80
Saving 54%

**Driven at 16.8 mph (average Greater London speed according to TfL Report http://content.tfl.gov.uk/tlrn-performance-report-q1-2017-18.pdf)

Jonathan Hampson continued: "Zipcar Flex gives Londoners even greater flexibility to get around their city how they want to. It works hand-in-hand with public transport, cycling and walking to give Londoners the broadest choice to choose the right mode of transport when it comes to their specific journey needs.

"It's about convenience, ease and saving money for members, but looking at the bigger picture, it's also about taking more cars off London's roads and helping to address the worsening issues of air quality and congestion, which we know are important to Londoners.

"Our research*** has shown that over half of Londoners have considered leaving London to live elsewhere in the past 12 months, with traffic, congestion, poor air quality and pollution levels cited as key issues. But attitudes need to change, people need to stop assuming that car ownership is a given and consider options available to them."

Regular Zipcar Flex user, James Lamb from Wandsworth, said: "We used to own two cars, but now we only own one - and I'm considering ditching that too. We use a mix of Zipcar Roundtrip and Zipcar Flex, for shorter errands, all the time, it just makes much more sense living in a big city. And we've saved a lot of money since selling off the second car."

For more information please visit http://www.zipcar.co.uk/flex

*Based on 2011 UK Census population figures:  Merton 203,200, Wandsworth 306,995, Islington 215,667, Hackney 246,300, Lewisham 275,885, Lambeth 327,900, Waltham Forest 265,800

***Independent research carried out in May 2017 by Vitreous World amongst 2,000 Londoners on behalf of Zipcar

About Zipcar
Zipcar is the world's leading car sharing network, driven by a mission to enable simple and responsible urban living. With its wide variety of self-service vehicles available by the hour or day, Zipcar operates in urban areas and university campuses in over 500 cities and towns across Belgium, Canada, Costa Rica, France, Iceland, Spain, Taiwan, Turkey, the United Kingdom and the United States. Zipcar offers the most comprehensive, most convenient and most flexible car sharing options available. Zipcar is a subsidiary of Avis Budget Group, Inc. (Nasdaq:CAR), a leading global provider of mobility solutions. More information is available at www.zipcar.com.

For more information:
Zipcar UK Enquiries
Email: zipcaruk@theprnetwork.co.uk




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Zipcar via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum